<Disease><Name>INFLAMMATORY BOWEL DISEASE (IBD) [DD]</Name><Synonym /><OMIM><Number>---</Number><URL>http://omim.org/entry/---</URL></OMIM><Orphanet><Number>---</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=---</URL></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number>---</Number><URL>http://enzyme.expasy.org/EC/---</URL></ExPASy><Gene>---Detail information to gene locus by the National Center for Biotechnology Information NCBI:

MAJOR HISTOCOMPATIBILITY COMPLEX
</Gene><ICD>K50.-, K51.-</ICD><Summary>Ulcerative colitis;Crohn&#226;&#8364;&#8482;s disease;multifactorial;NMR-based metabolomic fingerprinting of serum and urine has the potential to be a useful tool in distinguishing patients with active IBD from those in remission [Dawiskiba D 2014]</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2129</id><symptom>arthritis</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1713</id><symptom>fever, severe or recurrent</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3814</id><symptom>hemorrhagic diarrhea, chronic</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3169</id><symptom>oral infections, ulcerations, gangrene</symptom><category>HEAD</category></symtomp><symtomp><id>1975</id><symptom>pain, abdominal / pain abdominal</symptom><category>BODY | GENERAL TOPICS</category></symtomp><symtomp><id>2170</id><symptom>weight loss</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1586</id><name>5-Aminopentanoic acid</name><specimen>urine</specimen><value>increased</value><min>1.10</min><max>1.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1594</id><name>Allantoin</name><specimen>urine</specimen><value>increased</value><min>4.90</min><max>29.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>1601</id><name>Butyric Acid</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1714</id><name>Butyric Acid</name><specimen>urine</specimen><value>increased</value><min>26.00</min><max>34.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1733</id><name>Acetoine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1753</id><name>5-Aminopentanoic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>170.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1827</id><name>4-Pyridoxic acid</name><specimen>urine</specimen><value>increased</value><min>11.00</min><max>92.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1830</id><name>Allantoin</name><specimen>urine</specimen><value>increased</value><min>19.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1846</id><name>D-Mannitol</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>430.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1847</id><name>D-Mannose</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>310.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1874</id><name>D-Mannitol</name><specimen>urine</specimen><value>increased</value><min>5.20</min><max>85.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>75</id><name>3-Methyl-2-oxovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>372</id><name>3-Methyl-2-oxovaleric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>8.00</max><unit /><age>child</age><method /><comment /></metabolite><metabolite><id>373</id><name>3-Methyl-2-oxovaleric acid</name><specimen>plasma</specimen><value>increased</value><min>8.00</min><max>31.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1360</id><name>3-Methyl-2-oxovaleric acid</name><specimen>urine</specimen><value>increased</value><min>    </min><max>7.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1726</id><name>3-Methyl-2-oxovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>3-Methyl-2-ketovaleric acid statt 2-Methyl-3-ketovaleric aci</comment></metabolite><metabolite><id>1585</id><name>4-Pyridoxic acid</name><specimen>urine</specimen><value>increased</value><min>0.40</min><max>7.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite></Metabolites><Literatures><literature><id>8116</id><title>A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeost</title><author>Goncalves P,</author><journal>Inflamm Bowel Dis</journal><year>2018</year><book /><volume>24</volume><number>3</number><pages>558-572</pages><co_aut>Araujo JR, Di Santo JP</co_aut></literature><literature><id>8118</id><title>Protective Mechanisms of Butyrate on Inflammatory Bowel Disease</title><author>Silva JPB,</author><journal>Curr Pharm Des</journal><year>2018</year><book /><volume>24</volume><number>35</number><pages>4154-4166</pages><co_aut>et al.</co_aut></literature><literature><id>8117</id><title>Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases</title><author>Sun M,</author><journal>J Gastroenterol</journal><year>2017</year><book /><volume>52</volume><number>1</number><pages>1-8</pages><co_aut>et al.</co_aut></literature><literature><id>8081</id><title>Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases</title><author>Dawiskiba T,</author><journal>World J Gastroenterol</journal><year>2014</year><book /><volume>20</volume><number>1</number><pages>163-174</pages><co_aut>et al.</co_aut></literature><literature><id>8083</id><title>Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individua</title><author>Schicho R,</author><journal>J Proteome Res</journal><year>2012</year><book /><volume>11</volume><number>6</number><pages>3344-3357</pages><co_aut>et al.</co_aut></literature><literature><id>8082</id><title>Characterization of inflammatory bowel disease with urinary metabolic profiling</title><author>Williams HRT,</author><journal>Am J Gastroenterol</journal><year>2009</year><book /><volume>104</volume><number>6</number><pages>1435-1444</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>